B‐type natriuretic peptide for risk stratification in community‐acquired pneumonia
Authors:
Open Access
- 13 September 2005
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 258 (4) , 391-393
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Management of Community-Acquired PneumoniaNew England Journal of Medicine, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 2001
- Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?The American Journal of Medicine, 1999
- Interleukin-1β Regulation of the Human Brain Natriuretic Peptide Promoter Involves Ras-, Rac-, and p38 Kinase–Dependent Pathways in Cardiac MyocytesHypertension, 1999
- Prognosis and Decisions in PneumoniaNew England Journal of Medicine, 1997
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- Prognosis and Outcomes of Patients With Community-Acquired PneumoniaJAMA, 1996
- Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysisJAMA, 1996